Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)

NCT04704713 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Polymorphic Light Eruption

Interventions

DRUG: Afamelanotide
DRUG: Placebo

Sponsor

Clinuvel Pharmaceuticals Limited